Senators question Gilead Sciences CEO about pricey Hepatitis C drug, Sovaldi
Senate Finance Committee Chairman Ron Wyden, D-Ore., and senior Finance Committee member Chuck Grassley, R-Iowa, Friday requested detailed pricing information on a costly new Hepatitis C virus (HCV) drug. Wyden More...
Hepatitis C drug, Sovaldi, receives FDA nod
The U.S. Food and Drug Administration (FDA) approved Sovaldi (sofosbuvir) to treat chronic hepatitis C virus (HCV) infection yesterday. Sovaldi is the first drug that has demonstrated safety and efficacy to treat More...
